EWA
AGIO icon

EverSource Wealth Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

EverSource Wealth Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.9K Buy
535
+489
+1,063% +$14.8K ﹤0.01% 2436
2026
Q1 		$1.55K Buy
46
+12
+35% +$340 ﹤0.01% 3721
2025
Q4 		$926 Sell
34
-28
-45% -$982 ﹤0.01% 3728
2025
Q3 		$2.49K Hold
62
– – ﹤0.01% 3451
2025
Q2 		$2.06K Buy
62
+21
+51% +$637 ﹤0.01% 3500
2025
Q1 		$1.2K Sell
41
-6
-13% -$199 ﹤0.01% 3160
2024
Q4 		$1.54K Buy
47
+26
+124% +$1.22K ﹤0.01% 2815
2024
Q3 		$933 Hold
21
– – ﹤0.01% 2743
2024
Q2 		$974 Hold
21
– – ﹤0.01% 2747
2024
Q1 		$683 Sell
21
-38
-64% -$1.02K ﹤0.01% 2658
2023
Q4 		$1.31K Buy
+59
New +$1.32K ﹤0.01% 2308
2023
Q2 		– Sell
-56
Closed -$1.29K – 2494
2023
Q1 		$1.29K Buy
+56
New +$1.49K ﹤0.01% 2058

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

EverSource Wealth Advisors's AGIO Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Agios Pharmaceuticals (AGIO) stake by 1,063% in Q2 2026, buying an estimated $14.8K and bringing the position to 535 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2436.

EverSource Wealth Advisors first reported a position in AGIO in Q1 2023 and has held it in 12 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • EverSource Wealth Advisors held 535 shares of Agios Pharmaceuticals worth $19.9K as of Q2 2026.
  • EverSource Wealth Advisors bought 489 Agios Pharmaceuticals shares in Q2 2026, an estimated $14.8K.
  • Agios Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2436 holding.
  • EverSource Wealth Advisors first reported a position in Agios Pharmaceuticals in Q1 2023 and has held it in 12 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.